1996
Serum sickness consists of a systemic reaction resulting from the formation of soluble circulating immunocomplexes after the introduction of a foreign substance into the body We studied a 38-year-old woman diagnosed with anxiety, depression and right sacroileitis who was treated with phenylbutazone, ranitidine, clomipramine and levomepromazine.
 a 38-year-old woman diagnosed with anxiety, depression and right sacroileitis: Subject; 38-year-old: Subject.Age; woman: Subject.Gender; phenylbutazone, ranitidine, clomipramine and levomepromazine: Treatment; phenylbutazone: Treatment.Drug; clomipramine: Treatment.Drug; levomepromazine: Treatment.Drug; ranitidine: Treatment.Drug; anxiety, depression and right sacroileitis: Treatment.Disorder; levomepromazine: Combination.Drug; clomipramine: Combination.Drug; ranitidine: Combination.Drug; phenylbutazone: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: potential therapeutic event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Treatment.Time_elapsed, Subject.Disorder, Subject.Race, Treatment.Route, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 a 38-year-old woman diagnosed with anxiety, depression and right sacroileitis: Subject; 38-year-old: Subject.Age; woman: Subject.Gender; phenylbutazone, ranitidine, clomipramine and levomepromazine: Treatment; phenylbutazone: Treatment.Drug; clomipramine: Treatment.Drug; levomepromazine: Treatment.Drug; ranitidine: Treatment.Drug; anxiety, depression and right sacroileitis: Treatment.Disorder; levomepromazine: Combination.Drug; clomipramine: Combination.Drug; ranitidine: Combination.Drug; phenylbutazone: Combination.Drug